GlassScriptPhysician profile
Elizabeth Andersen
NPI 1043701220
$2,028.43
in general payments reported to CMS, 2019-2025
17 companies · $657 in 2025
The $657 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.25 · 2023: $944 · 2024: $406 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,875 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,874.91 |
| Education | $131.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $305.87 | 2023-2025 | |
| Abbvie INC. | $256.52 | 2023-2025 | Ubrelvy, Qulipta, Synthroid |
| Novo Nordisk INC | $238.68 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $208.20 | 2023-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Astellas Pharma US INC | $155.89 | 2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $143.95 | 2022-2025 | Airsupra, Fasenra, Breztri |
| Axogen | $127.50 | 2023 | Avance Nerve Graft |
| Amgen INC. | $126.12 | 2023-2025 | Repatha, Otezla, Repatha |
| Exact Sciences Corporation | $116.57 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.73 | 2023-2025 | Jardiance |
| Lilly USA, LLC | $75.32 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Dynavax Technologies Corporation | $46.97 | 2023-2024 | Heplisav-B |
| Vivus LLC | $38.35 | 2023 | Qsymia |
| Daiichi Sankyo INC. | $37.56 | 2023-2025 | Injectafer |
| Inspire Medical Systems, INC. | $34.54 | 2024 | Inspire |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $23.62 | 2024 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.04 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.